Erratum: Dihydropyrimidine dehydrogenase: A flavoprotein with four iron-sulfur clusters (Biochimica et Biophysica Acta (2004) 1701 (61-74) DOI: 10.1016/j.bbapap.2004.06.009);Dihydropyrimidine dehydrogenase: A flavoprotein with four iron-sulfur clusters

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1701, Issue 1-2, 2004, Pages 61-74

  Schnackerz, Klaus D ^a   Dobritzsch, Doreen ^b   Lindqvist, Ylva ^b   Cook, Paul F ^c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Chemical mechanism; Dihydropyrimidine dehydrogenase; FeS cluster; Flavin; Kinetic mechanism; Pyrimidine degradation

Indexed keywords

DEUTERIUM; DIHYDROPYRIMIDINE DEHYDROGENASE; DIMER; FLAVINE ADENINE NUCLEOTIDE; FLAVINE MONONUCLEOTIDE; FLAVOPROTEIN; FLUOROURACIL; IRON SULFUR PROTEIN; ISOTOPE; MONOMER; PYRIMIDINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCING AGENT; SOLVENT;

ARTICLE; BINDING SITE; CATALYSIS; DRUG DEGRADATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG STRUCTURE; ELECTRON TRANSPORT; HUMAN; NEUROLOGIC DISEASE; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; PROTON TRANSPORT; REDUCTION; TOXICITY;

EID: 4344610196     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2004.10.007     Document Type: Erratum

References (38)

1. D.H. Ho, L. Townsend, M.A. Luna, and G.P. Bodeley Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate Anticancer Res. 6 1986 781 784
2. C. Wasternack Degradation of pyrimidines and pyrimidine analogsâ€"pathways and mutual influences Pharmacol. Ther. 8 1980 629 651
3. J.M. Williamson, and G.M. Brown Purification and properties of l-aspartate-alpha-decarboxylase, an enzyme that catalyzes the formation of beta-alanine in Escherichia coli J. Biol. Chem. 254 1979 8074 8082
4. D. Papamichael The use of thymidylate synthase inhibitors in the treatment of advanced colorectal cancer: current status Stem Cells 18 2000 166 185
5. G. Milano, and M.-C. Etienne Dihydropyrimidine dehydrogenase (DPD) and clinical pharmacology of 5-fluorouracil Anticancer Res. 14 1994 2295 2297
6. 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with and without methotrexate pretreatment Cancer Res. 48 1988 1680 1688
7. R.A. Brito, D. Medgyesy, T.H. Zukowski, M.E. Royce, F. Ravandi-Kashani, P.M. Hoff, and R. Pazdur Fluoropyrimidines: a critical evaluation Oncology 57 Suppl. 1 1999 2 8
8. A.B.P. van Kuilenburg, J. Haqasjes,. J Richel, L. Zoetekouw, H. Lenthe, R.A. Abreu, and A.H. van Gennip Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene Clin. Cancer Res. 6 2000 4705 4711
9. A.B.P. van Kuilenburg, E.W. Muller, J. Haasjes, R. Meinsma, L. Zoetkouw, H.R. Waterham, F. Baas, D.J. Richel, and A.H. van Gennip Lethal outcome of a patient with a complete dihydropyrimidine dehydrogenase (DPD) deficiency after administration of 5-fluorouracil: frequency of the common IVS14+1G>A mutation causing DPD deficiency Clin. Cancer Res. 7 2001 1149 1153
10. E.S.R. Collie-Duguid, M.C. Etienne, G. Milano, and H.L. McLeod Known variant DPYD alleles do not explain DPD deficiency in cancer patients Pharmacogenetics 10 2000 217 233
11. A.B.P. van Kuilenburg, P. Vreken, N.G. Abeling, H.D. Bakker, R. Meinsma, H. Van Lenthe, R.A. De Abreu, J.A. Smeitink, H. Layserili, M.Y. Apak, E. Christensen, I. Holopainen, K. Pulkki, D. Riva, G. Botteon, E. Holame, M. Tulinius, W.J. Kleijer, F.A. Beemer, M. Duran, K.E. Niezen-Koning, G.P. Smit, C. Jacobs, L.M. Smit, and A.H. Van Gennip Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency Hum. Genet. 104 1999 1 9
12. A.H. van Gennip, N.G.G.M. Aebeling, P. Vreken, and A.B.P. van Kuilenburg Inborn error of pyrimidine degradation: clinical, biochemical and molecular aspects J. Inherit. Metab. Dis. 20 1997 203 213
13. A.B.P. van Kuilenburg, D. Dobritzsch, R. Meinsma, J. Haasjes, H.R. Waterham, M.J.M. Nowaczyk, G.D. Maropoulos, G. Hein, H. Kalhoff, J.M. Kirk, H. Baaske, A. Aukett, J.A. Duley, K. Wards, Y. Lindqvist, and A.H. Van Gennip Novel disease-causing mutations in the dihydropyrimidine gene interpreted by analysis of the three-dimensional protein structure Biochem. J. 364 2002 157 163
14. P. Vreken, A.B.P. van Kuilenburg, R. Meinsma, and A.H. van Gennip Dihydropyrimidine dehydrogenase (DPD) deficiency: identification and expression of missense C29R, R886H and R235W Hum. Genet. 101 1997 333 338
15. T. Shiotani, and G. Weber Purification and properties of dihydrothymine dehydrogenase from rat liver J. Biol. Chem. 256 1981 219 224
16. B. Podschun, G. Wahler, and K.D. Schnackerz Purification and characterization of dihydropyrimidine dehydrogenase from pig liver Eur. J. Biochem. 185 1989 219 224
17. K. Rosenbaum, B. Schaffrath, W.R. Hagen, K. Jahnke, F.J. Gonzalez, P.F. Cook, and K.D. Schnackerz Purification, characterization, and kinetics of porcine dihydropyrimidine Protein Expr. Purif. 10 1997 185 191
18. D.J.T. Porter, W.G. Chestnut, L.C.E. Taylor, and T. Spector Inactivation of dihydropyrimidine dehydrogenase by 5-iodouracil J. Biol. Chem. 266 1991 19988 19994
19. Z.H. Lu, R. Zhang, and R.B. Diasio Purification and characterization of dihydropyrimidine dehydrogenase from human liver J. Biol. Chem. 267 1992 17102 17109
20. U. Schmitt, K. Jahnke, K. Rosenbaum, P.F. Cook, and K.D. Schnackerz Purification and characterization of dihydropyrimidine dehydrogenase from Alcaligenes eutrophus Arch. Biochem. Biophys. 332 1996 175 182
21. K. Rosenbaum, K. Jahnke, B. Curti, W.R Hagen, K.D. Schnackerz, and M.A. Vanoni Porcine recombinant dihydropyrimidine dehydrogenase: comparison of the spectroscopic and catalytic properties of the wild-type and C671A mutant enzymes Biochemistry 37 1998 17598 17609
22. H. Yokota, P. Fernandez-Salguero, H. Furuya, K. Lin, O.W. McBride, B. Podschun, K.D. Schnackerz, and F.J. Gonzalez cDNA cloning and chromosome mapping of human dihydropyrimidine dehydrogenase, an enzyme associated with 5-fluorouracil toxicity and congenital thymine uraciluria J. Biol. Chem. 269 1994 23192 23196
23. W.R. Hagen, M.A. Vanoni, K. Rosenbaum, and K.D. Schnackerz On the ironâ€"sulfur clusters in the complex redox enzyme dihydropyrimidine dehydrogenase Eur. J. Biochem. 267 2000 3460 3646
24. D. Dobritzsch, G. Schneider, K.D. Schnackerz, and Y. Lindqvist Crystal structure of dihydropyrimidine dehydrogenase, a major determinant of the pharmacokinetics of the anti-cancer drug 5-fluorouracil EMBO J. 20 2001 650 660
25. M. Bruschi, and F. Guerlesquin Structure, function and evolution of bacterial ferredoxins FEMS Microbiol. Rev. 54 1988 155 176
26. B. Podschun, P.F. Cook, and K.D. Schnackerz Kinetic mechanism of dihydropyrimidine dehydrogenase from pig liver J. Biol. Chem. 265 1990 12966 12972
27. V. Hines, and M. Johnston Analysis of the kinetic mechanism of the bovine liver dihydroorotate dehydrogenase Biochemistry 28 1986 1222 1226
28. D.J.T. Porter, and T. Spector Dihydropyrimidine dehydrogenase. Kinetic mechanism for reduction of uracil by NADPH J. Biol. Chem. 268 1993 19321 19327
29. B. Podschun, K. Jahnke, K.D. Schnackerz, and P.F. Cook Acid base catalytic mechanism of the dihydropyrimidine dehydrogenase from pH studies J. Biol. Chem. 268 1993 3407 3413
30. D.J.T. Porter, W.G. Chestnut, B.M. Merril, and T. Spector Mechanism-based inactivation of dihydropyrimidine dehydrogenase by 5-ethynyluracil J. Biol. Chem. 267 1992 5236 5242
31. B. Podschun Stereochemistry of NADPH oxidation by dihydropyrimidine dehydrogenase from pig liver Biochem. Biophys. Res. Commun. 182 1992 609 616
32. D. Dobritzsch, S. Ricagno, G. Schneider, K.D. Schnackerz, and Y. Lindqvist Crystal structure of productive ternary complex of dihydropyrimidine dehydrogenase with NADPH and 5-iodouracil. Implications for the mechanism of inhibition and electron transfer J. Biol. Chem. 277 2002 13155 13166
33. C.C. Page, C.C. Moser, X. Chen, and P.L. Dutton Natural engineering principles of electron tunnelling in biological oxidationâ€" reduction Nature 402 1999 47 52
34. K. Rosenbaum, K. Jahnke, K.D. Schnackerz, and P.F. Cook Secondary tritium and solvent deuterium isotope effects as a probe of the reaction catalyzed by porcine recombinant dihydropyrimidine dehydrogenase Biochemistry 37 1998 9156 9159
35. H. Yokota, P. Fernandez-Salguero, H. Furuya, K. Lin, O.W. McBride, B. Podschun, K.D. Schnackerz, and F.J. Gonzalez cDNA cloning and chromosome mapping of human dihydropyrimidine dehydrogenase, an enzyme associated with 5-fluorouracil toxicity and congenital thymine uraciluria J. Biol. Chem. 269 1994 23192 23196
36. M. Kimura, S.F. Sakata, Y. Matoba, K. Matsuda, Y. Kontani, M. Kaneko, and N. Tamaki Cloning of rat dihydropyrimidine dehydrogenase and correlation of its mRNA increase in the rat liver with age J. Nutr. Sci. 44 1998 537 546
37. G. Milano, and M.C. Etienne Dihydropyrimidine dehydrogenase (DPD) and clinical pharmacology of 5-fluorouracil Anticancer Res. 14 1994 2295 2297
38. T. Kubota 5-Fluorouracil and dihydropyrimidine dehydrogenase Int. J. Clin. Oncol. 8 2003 127 131